These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10346882)

  • 21. Usage of radiopharmaceuticals in the development of pharmaceutical drug delivery systems: validation of [99mTc]DTPA and [99mTc]ECD.
    Terán M; Savio E; Paolino A; Frier M
    Eur J Pharm Biopharm; 2004 Mar; 57(2):347-52. PubMed ID: 15018995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatty acid oxidation is decreased in the liver of ovariectomized rats.
    Paquette A; Chapados NA; Bergeron R; Lavoie JM
    Horm Metab Res; 2009 Jul; 41(7):511-5. PubMed ID: 19241328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in the intracellular processing of the radiolabel following the uptake of iodine-125- and technetium-99m-neogalactosyl albumin by the isolated perfused rat liver.
    Gore S; Morris AI; Gilmore IT; Maltby PJ; Thornback JR; Billington D
    J Nucl Med; 1991 Mar; 32(3):506-11. PubMed ID: 2005461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
    Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
    Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic analysis of 123I-labeled medium chain fatty acid as a radiopharmaceutical for hepatic function based on beta-oxidation.
    Yamamura N; Magata Y; Yamashita F; Hashida M; Saji H
    Ann Nucl Med; 1999 Aug; 13(4):235-9. PubMed ID: 10510879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
    Igoudjil A; Massart J; Begriche K; Descatoire V; Robin MA; Fromenty B
    Toxicol In Vitro; 2008 Jun; 22(4):887-98. PubMed ID: 18299183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer.
    Wong M; Evans S; Rivory LP; Hoskins JM; Mann GJ; Farlow D; Clarke CL; Balleine RL; Gurney H
    Clin Pharmacol Ther; 2005 Jan; 77(1):33-42. PubMed ID: 15637529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation in muscle and liver lipogenic genes: EPA ethyl ester treatment in lean and overweight (high-fat-fed) rats.
    Pérez-Echarri N; Pérez-Matute P; Marcos-Gómez B; Marti A; Martínez JA; Moreno-Aliaga MJ
    J Nutr Biochem; 2009 Sep; 20(9):705-14. PubMed ID: 18829285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo oxidation of [9-14C] cyclic fatty acids derived from linolenic acid in the rat.
    Bretillon L; Loreau O; Sébédio JL; Taran F
    Reprod Nutr Dev; 2006; 46(2):189-93. PubMed ID: 16597424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary sesamin and docosahexaenoic and eicosapentaenoic acids synergistically increase the gene expression of enzymes involved in hepatic peroxisomal fatty acid oxidation in rats.
    Arachchige PG; Takahashi Y; Ide T
    Metabolism; 2006 Mar; 55(3):381-90. PubMed ID: 16483883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extension of the single amino acid chelate concept (SAAC) to bifunctional biotin analogues for complexation of the M(CO)3(+1) Core (M = Tc and Re): syntheses, characterization, biotinidase stability, and avidin binding.
    James S; Maresca KP; Allis DG; Valliant JF; Eckelman W; Babich JW; Zubieta J
    Bioconjug Chem; 2006; 17(3):579-89. PubMed ID: 16704194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver.
    García-Villafranca J; Guillén A; Castro J
    Biochimie; 2008 Mar; 90(3):460-6. PubMed ID: 17997005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of radioiodinated medium chain fatty acids as new diagnostic agents for the determination of hepatic viability.
    Yamamura N; Magata Y; Konishi J; Saji H
    Eur J Nucl Med; 1999 Dec; 26(12):1597-605. PubMed ID: 10638412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of photoactivation in the preparation of radiopharmaceuticals. II. Dialysate of human leukocytes labelled with technetium (99mTc)].
    Kleisner I; Komárek P; Konopková M; Komárková I
    Ceska Slov Farm; 1997 Aug; 46(4):169-73. PubMed ID: 9377062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microautoradiographic study of technetium-99m colloid uptake by the rat liver.
    Hindie E; Colas-Linhart N; Petiet A; Bok B
    J Nucl Med; 1988 Jun; 29(6):1118-21. PubMed ID: 3373320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of photoactivation in the preparation of radiopharmaceuticals. I. Human immunoglobulin labelled with technetium (99mTc)].
    Komárek P; Kleisner I; Konopková M; Komárko I
    Ceska Slov Farm; 1997 Jun; 46(3):122-7. PubMed ID: 9440949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc.
    Hambright P; McRae J; Valk PE; Bearden AJ; Shipley BA
    J Nucl Med; 1975 Jun; 16(6):478-82. PubMed ID: 808594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progestin radiopharmaceuticals labeled with technetium and rhenium: synthesis, binding affinity, and in vivo distribution of a new progestin N2S2-metal conjugate.
    O'Neil JP; Carlson KE; Anderson CJ; Welch MJ; Katzenellenbogen JA
    Bioconjug Chem; 1994; 5(3):182-93. PubMed ID: 7918738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of 99mtechnetium-radiopharmaceutical binding to blood elements using different trichloroacetic acid concentrations.
    Freitas RS; Gutfilen B; da Fonseca LM; Bernardo-Filho M
    Yale J Biol Med; 1996; 69(6):483-8. PubMed ID: 9436291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.